Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC) Meeting Abstract
| Authors: | Wongchenko, M. J.; Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I.; Andersen, J.; Coelho, J. I. P.; Gil, M. G.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; Singel, S. M.; Maslyar, D. J.; Xu, N.; de la Pena, L.; Baselga, J.; Gendreau, S.; Isakoff, S. J. |
| Abstract Title: | Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (TNBC) |
| Meeting Title: | 41st Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Dec 4-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000478677000438 |
| DOI: | 10.1158/1538-7445.Sabcs18-p2-08-19 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-08-19 -- Source: Wos |
